Recall -- Firm Press Release
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.
Teva Animal Health, Inc. expands a voluntary nationwide recall of Ketamine Hydrochloride Injection, USP CIII 100mg/mL in 10mL vials
FOR IMMEDIATE RELEASE -- December 21, 2009 - Teva Animal Health, Inc. is expanding a nationwide voluntary recall of Ketamine Hydrochloride Injection, USP CIII 100mg/mL in 10mL vials for all lot numbers within their expiration dates to the Veterinary Level. This product had previously been recalled to the distributor level and is being expanded as a result of an increased trend in serious adverse events associated with this product.
Veterinarians who have this product in their possession are instructed to cease using the product immediately and return it to their distributor.
Ketamine Hydrochloride is a rapid acting, non-narcotic, non-barbiturate agent for anesthetic use in cats and for restraint in subhuman primates. This recall is being conducted as a result of an increased trend in serious adverse events associated with this product, including lack of effect, prolonged effect, and death and involves all lot numbers within expiration.
Teva Animal Health, Inc is voluntarily recalling the aforementioned product. The FDA has been apprised of this action.
Consumers with questions may contact 800-759-3664 from 8:00am – 5:00pm CST Monday-Friday.